Corcept Therapeutics | Umlaufvermögen

Aktienkurs
35.70
Täglich Wechseln
-0.08 -0.22%
Monatlich
-22.14%
Jährlich
-41.07%
Q1 Prognose
34.60




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Ardelyx USD 367.98M 16.42M 2025-09
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 423.84M 41.46M 2025-09
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 445.82M 142.46M 2025-09
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
J&J USD 55.62B 1.01B 2025-12
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Lexicon Pharmaceuticals USD 145.08M 100.72M 2025-06
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Novartis USD 28.2B 2.26B 2025-09
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
TG Therapeutics USD 630.76M 31M 2025-12


Corcept Therapeutics Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.